In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli-Reference-Cited by-同舟云学术

In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli

Published:2020-01-27 Issue:2 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Fleischmann Wim A.¹²,Greenwood-Quaintance Kerryl E.²,Patel Robin²³^ORCID

Affiliation:

1. Paracelsus Medical University, Salzburg, Austria

2. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

3. Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA

Abstract

The worldwide spread of multidrug-resistant Enterobacterales is a serious threat to public health. Here, we compared the MICs of plazomicin, amikacin, gentamicin, and tobramycin against 303 multinational multidrug-resistant Gram-negative bacilli. We followed Clinical and Laboratory Standards Institute (CLSI) guidelines and applied CLSI breakpoints as well as those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for amikacin, gentamicin, and tobramycin and of the U.S.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01711-19

Reference36 articles.

1. U.S. Department of Health and Human Services Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States 2013. https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed 21 April 2019.

2. World Health Organization. 2017. Global priority list of antibiotic-resistant bacteria to guide research discovery and development of new antibiotics. https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/. Accessed 21 April 2019.

3. Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance

4. Progressive Increase in Antibiotic Resistance of Gram-negative Bacterial Isolates

5. Aminoglycoside modifying enzymes

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli;Acta Microbiologica et Immunologica Hungarica;2024-07-02

2. In vitro activity of plazomicin and other aminoglycosides against Klebsiella pneumoniae multidrug-resistant strains;The Journal of Antibiotics;2024-05-08

3. Aminoglycoside antibiotics: Trying to find a place in this world;Clinical Microbiology Newsletter;2024-04

4. Epidemiology, Clinical, and Microbiological Characteristics of Multidrug-Resistant Gram-Negative Bacteremia in Qatar;Antibiotics;2024-03-31

5. Impact of Antibiotic Prophylaxis on Surgical Site Infections in Cardiac Surgery;Antibiotics;2023-01-04